---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-015522"
form_type: "8-K"
ticker: "BJDX"
cik: "0001704287"
company_name: "Bluejay Diagnostics, Inc."
filed_at: "2022-03-28T23:59:59+00:00"
generated_at: "2026-06-26T16:14:46.408087+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Bluejay Diagnostics appoints Kenneth Fisher as CFO with $275K salary; Kinder resigns

## Summary
- Kenneth Fisher appointed CFO effective March 23, 2022; Gordon Kinder resigned same day.
- Employment agreement: $275K annual salary (increases to $300K on Jan 1, 2023), target annual bonus 40% of base.
- Received 10-year option for 65,000 shares at $1.31/share; 5,000 vested immediately, 60,000 vest over 3 years.
- Severance: six months base salary plus pro rata bonus if terminated without cause.
- Fisher's prior role: EVP, CFO and Treasurer of Meridian Bancorp (merged with Rockland Trust in Nov 2021).

## SEC filing metadata
- accession: 0001213900-22-015522
- form_type: 8-K
- ticker: BJDX
- cik: 0001704287
- company_name: Bluejay Diagnostics, Inc.
- filed_at: 2022-03-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1704287/000121390022015522/0001213900-22-015522-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1704287/000121390022015522/ea157473-8k_bluejay.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-015522
- JSON: https://secwatch.observer/filing/0001213900-22-015522.json
- Plain text: https://secwatch.observer/filing/0001213900-22-015522.txt

## Key facts
- Executive change
  Gordon Kinder resigned as Chief Financial Officer at Bluejay Diagnostics, Inc..
  - Action: resigned
  - Role: Chief Financial Officer
  source text: On March 23, 2022, the Company accepted the resignation of Mr. Gordon Kinder from his position as Chief Financial Officer effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390022015522/0001213900-22-015522-index.htm
- Executive change
  Kenneth Fisher was appointed as Chief Financial Officer at Bluejay Diagnostics, Inc..
  - Action: appointed
  - Role: Chief Financial Officer
  source text: On March 23, 2022, Bluejay Diagnostics, Inc. (the “Company”) entered into an employment agreement with Mr. Kenneth Fisher pursuant to which Mr. Fisher agreed to serve as Chief Financial Officer of the Company commencing on such date.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1704287/000121390022015522/0001213900-22-015522-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.